FDA Investigator Seongeun Cho (Julia), PhD

Seongeun Cho (Julia), PhD has conducted inspections on 7 sites in 4 countries as of 14 Sep 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

14 Sep 2022

Investigator Role:

FDA Investigator

Redica ID:

100005597

Countries of Inspections:

United States of America, Canada, Spain, India

FDA Investigators that have inspected at least one site in common with Seongeun Cho (Julia), PhD:

Andrea D Swingle, Angel S Johnson, Anita R Michael, Arindam Dasgupta, PhD, Barbara A Rusin, Barbara M Frazier, Benton M Ketron, CDR Kimberly Y Martin, Craig A Garmendia, David M Mcnew, Dawn C Olenjack, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Felix Maldonado, Gabriel Davila, Gary T Greco, George C Amedro, Himanshu Gupta, PhD, Jacqueline Mdiaz Albertini, James M Mason, Jennifer L Sheehan, Joanne M Schlossin, John A Kadavil, PhD, Jonathan G Matrisciano, Joseph L Despins, PhD, Junho Pak, Kara A Scheibner, PhD, Karen L Kosar, Karen M Cooper, Kerun Hardeo, Larry K Austin, Laura E Garcia, Lawrence Y Lee, PhD, LCDR Chad N Thompson, Li Hongpaul Yeh, PhD, Lisa P Oakes, Makini Cobourne Duval, PhD, Margaret E Sarles, Martin K Yau, PhD, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael G Sinkevich, Mohsen Rajabi Abhari, FDA, Nancy A Bellamy, Nicholas C Mendiola, Nicola M Fenty Stewart, Paula M Laplant, Russ E Davis, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Sheri L Stephenson, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stanley Au, Susan D Yuscius, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiying E Chen, Yiyue Zhang (nmi), PhD

Seongeun Cho (Julia), PhD's Documents

Publish Date	Document Type	Title
January, 2015	EIR	ICON Development Solutions, LLC - EIR, 2016-08-31
February, 2019	FDA 483	Pharmaron (Exton) Lab Services LLC - Form 483, 2019-02-01
February, 2019	FDA 483 Response	Pharmaron (Exton) Lab Services LLC - Form 483R, 2019-02-22
May, 2013	FDA 483	Syneos Health Clinique Inc - Form 483, 2013-05-10
June, 2017	FDA 483	Laboratorios Rubio SA - Form 483, 2017-06-23
February, 2019	EIR	Pharmaron (Exton) Lab Services LLC - EIR, 2019-02-01
October, 2012	FDA 483	COVANCE BIOANALYTICAL SERVICES, LLC - Form 483, 2012-10-19
September, 2022	FDA 483	The City College of New York/CUNY - Form 483, 2022-09-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more